Clinical Trials Browser

Phase NA × Interventional × HMPL-013 × Clear all

NCT06985316 2025-05-22

An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined With Fruquintinib in the Third-line Treatment of Advanced Colorectal Cancer Patients With RAS Mutations.

Phase NA Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06551207 2024-08-13

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Phase NA Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06317298 2024-03-19

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

Phase NA Recruiting

Carcinoma, Renal Cell